How embracing opposition sends clinicians home from COPHy with more useful takeaways

News
Video

The Congress on Controversies in Ophthalmology highlights debates, but also discussions

The Congress on Controversies in Ophthalmology (COPHy) is underway in Seville, Spain. This year, the 16th annual congress will run from 4-5 April, and ahead of the meeting, the Ophthalmology Times Europe team spoke with the COPHy co-chairs for the March/April cover story. Here, we see a clip from one of those interviews. Anat Loewenstein, MD, head of the Department of Ophthalmology at the Tel Aviv Medical Center in Tel Aviv, Israel, serves as a co-chair for the meeting and was happy to explain what makes COPHy different from other ophthalmology conferences. Watch the full video, or continue reading for a brief summary of the conversation.

One unique aspect of the COPHy meetings is its focus on controversial clinical topics. Each session includes three debates, in which two clinicians go head-to-head with affirmative and negative positions. Following each debate, there are ample 10-minute discussion periods, allowing for in-depth analysis. This structure also utilises skilled moderators, who facilitate a comprehensive summary of the debate and aim to synthesize together a conclusion of the debated points. According to Prof Loewenstein, this unique structure has the potential to influence clinical management practices significantly.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
© 2025 MJH Life Sciences

All rights reserved.